Covid 19
Patent oppositions filed in
Thailand and Viet Nam

Baricitinib belongs to Janus Kinase Inhibitor class of drugs. It is prescribed for treatment of rheumatoid arthritis, alopecia areata and Covid 19.

This drug is missing the following documents, can you help us by contributing something?


Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Thailand08-03-2023Thai Network of People Living with HIV/AIDS (TNP+)OtherUnder ExaminationOtherWO/2009/114512View/Comment
Viet Nam29-12-2022Vietnam National Network of People Living with HIV/AIDS (VNP+)Post-GrantUnder ExaminationMolecules14607 / WO2009114512A1View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top